Trial Profile
Effectiveness of Exjade in patients with transfusion-dependent β-thalassemia major during 3 years in Georgia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2018
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Beta-thalassaemia
- Focus Pharmacodynamics; Therapeutic Use
- 27 Jul 2018 New trial record
- 17 Jun 2018 Results presented at the 23rd Congress of the European Haematology Association